ALK, the second most common driver in neuroblastoma after MYCN, is a receptor tyrosine kinase which in the neuroblastoma context first attracted attention in conjunction with the rare hereditary neuroblastomas [15]. This evidence concerns the gene ALK and neuroblastoma.